DAWN
Day One Biopharmaceuticals, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$10.74
$-0.42
(-3.76%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $1.10B | EPS (ttm) | $-1.52 | Current Price | $10.74 |
| Enterprise Value | $654.05M | Forward EPS | $-0.59 | Previous Close | $11.16 |
| P/E Ratio | - | ROA | -18.58% | 52W High | $13.20 |
| Forward P/E | -18.30 | ROE | -30.16% | 52W Low | $5.63 |
| PEG Ratio | - | Gross Margin | 89.44% | 50 Day Avg | $9.71 |
| P/S Ratio | 8.25 | Operating Margin | -60.94% | 200 Day Avg | $7.76 |
| P/B Ratio | 2.45 | Profit Margin | -113.53% | Volume | 1.77M |
| EV/EBITDA | -4.03 | Current Ratio | 8.68 | Avg Volume | 2.96M |
| EV/Sales | 4.89 | Quick Ratio | 8.29 | Beta | -1.26 |
| Employees | 184.00 | Debt/Equity | 0.64 | Shares Outstanding | 102.68M |
| Sector | Healthcare | Total Debt | $2.89M | Float Shares | 78.93M |
| Industry | Biotechnology | Total Cash | $451.58M | Short Float | 16.38% |
| Optionable | Yes | Cash/Share | $4.40 | Short Ratio | 4.21 |
| Dividend Yield | - | Book Value/Share | $4.39 | % Held by Insiders | 16.94% |
| Target Price | $22.67 | Revenue (TTM) | $133.67M | % Held by Institutions | 86.03% |